Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03523533 · ClinicalTrials.gov registry record · NA

Peripherally Inserted Internal Jugular Catheters: an Observational Study

A NA study, sponsored by University of New Mexico.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT03523533: Clinical Trial NA study, sponsored by University of New Mexico.

NCT03523533 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03523533, a NA study, was terminated before completion, sponsored by University of New Mexico.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

This is an observational study intended to characterize the time-to-placement of peripherally-inserted internal jugular (PIJ) catheters in appropriate patients. As secondary outcomes and to ensure patient safety, the investigators will record and evaluate adverse outcomes, but the study is not powered to detect rare events.

Primary Outcome

Elapsed time from first contact of skin prep solution to completely secured/covered catheter

Interventions

  • PROCEDURE Angiocatheter

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-08-03
Est. Completion 2018-11-21
Phase NA
University of New Mexico

168 total trials

Why NCT03523533 stopped before completion

NCT03523533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Angiocatheter is the first listed.

NCT03523533 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03523533 about?

NCT03523533 is a clinical study titled "Peripherally Inserted Internal Jugular Catheters: an Observational Study". This is an observational study intended to characterize the time-to-placement of peripherally-inserted internal jugular (PIJ) catheters in appropriate patients. As secondary outcomes and to ensure patient safety, the investigators will record and evaluate adverse outcomes, but the study is not power...

What is the current status of trial NCT03523533?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2018-08-03. Estimated completion is 2018-11-21.

What interventions are being tested in trial NCT03523533?

The interventions under investigation include: Angiocatheter (PROCEDURE).

Who is sponsoring clinical trial NCT03523533?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03523533's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03523533, the US trial registry maintained by the National Library of Medicine. NCT03523533 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.